Masimo (NASDAQ:MASI) Updates FY 2025 Earnings Guidance

Masimo (NASDAQ:MASI - Get Free Report) updated its FY 2025 earnings guidance on Thursday. The company provided EPS guidance of 4.900-5.100 for the period, compared to the consensus EPS estimate of 4.670. The company issued revenue guidance of -. Masimo also updated its FY 2024 guidance to 4.100-4.100 EPS.

Analyst Upgrades and Downgrades

A number of analysts recently issued reports on MASI shares. Stifel Nicolaus restated a "buy" rating and set a $190.00 price objective (up previously from $170.00) on shares of Masimo in a report on Friday, November 22nd. BTIG Research raised their price target on shares of Masimo from $166.00 to $170.00 and gave the stock a "buy" rating in a research note on Monday, October 14th. Needham & Company LLC reiterated a "hold" rating on shares of Masimo in a research note on Thursday. Raymond James raised their target price on Masimo from $170.00 to $194.00 and gave the stock an "outperform" rating in a research report on Friday, December 27th. Finally, Wells Fargo & Company boosted their target price on Masimo from $171.00 to $193.00 and gave the company an "overweight" rating in a research note on Wednesday, December 11th. Three investment analysts have rated the stock with a hold rating and five have given a buy rating to the company's stock. According to MarketBeat, the stock has a consensus rating of "Moderate Buy" and a consensus target price of $179.67.

Masimo Stock Performance

Shares of NASDAQ MASI traded down $2.13 during mid-day trading on Thursday, hitting $169.94. The company had a trading volume of 992,781 shares, compared to its average volume of 535,351. The stock's 50-day moving average price is $169.03 and its 200-day moving average price is $139.75. The company has a market capitalization of $9.10 billion, a price-to-earnings ratio of 117.20 and a beta of 1.01. The company has a current ratio of 2.01, a quick ratio of 1.11 and a debt-to-equity ratio of 0.50. Masimo has a 1 year low of $101.61 and a 1 year high of $180.97.

Masimo (NASDAQ:MASI - Get Free Report) last announced its quarterly earnings results on Tuesday, November 5th. The medical equipment provider reported $0.98 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.84 by $0.14. The firm had revenue of $504.60 million for the quarter, compared to the consensus estimate of $502.87 million. Masimo had a net margin of 3.85% and a return on equity of 14.98%. The company's revenue for the quarter was up 5.4% on a year-over-year basis. During the same period in the prior year, the firm posted $0.63 earnings per share. On average, sell-side analysts forecast that Masimo will post 4.03 earnings per share for the current year.

About Masimo

Masimo Corporation develops, manufactures, and markets various patient monitoring technologies, and automation and connectivity solutions worldwide. The company offers masimo signal extraction technology (SET) pulse oximetry with measure-through motion and low perfusion pulse oximetry monitoring to address the primary limitations of conventional pulse oximetry; Masimo rainbow SET platform, including rainbow SET Pulse CO-Oximetry products that allows noninvasive monitoring of carboxyhemoglobin, methemoglobin, hemoglobin concentration, fractional arterial oxygen saturation, oxygen content, pleth variability index, rainbow pleth variability index, respiration rate from the pleth, and oxygen reserve index, as well as acoustic respiration monitoring, SedLine brain function monitoring, NomoLine capnography and gas monitoring, and regional oximetry.